How Complexity and Multiple Illnesses Affect Hospitalized Patients' Health: a Multicenter Study

March 10, 2025 updated by: Società Italiana di Medicina Interna

EFFETTI DELLA COMPLESSITÀ E MULTIMORBIDITÀ SUGLI ESITI CLINICI NEL PAZIENTE INTERNISTICO OSPEDALIZZATO: STUDIO MULTICENTRICO, OSSERVAZIONALE E PROSPETTICO - EFFECTS of COMPLEXITY and MULTIMORBIDITY on CLINICAL OUTCOMES in HOSPITALIZED INTERNAL MEDICINE PATIENTS: a MULTICENTER, OBSERVATIONAL and PROSPECTIVE STUDY

The goal of this observational study is to evaluate the association between complexity and multiple illnesses of adult hospitalized internal medicine patient and mortality. The observational study will also evaluate the association between pre-existing factors at hospitalization and clinical outcomes such as mortality, length of hospital stay, intensity of care (transfer to units with higher clinical intensity), complications and rehospitalization.

For data collection, four index weeks will be identified during the year in which the participating Centers will have to sequentially enroll all the participants who will be admitted to the Internal Medicine units, until reaching, for each index week, 10 participants for each of the Participating Centers.

Each enrolled participant will undergo a 12-month follow-up. The study foresees the enrollment of 2326 participants.

Study Overview

Study Type

Observational

Enrollment (Estimated)

2326

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Bari, Italy, 70124
        • Recruiting
        • AOU Policlinico di Bari- Unità Operativa di Medicina Interna "Guido Baccelli
        • Contact:
      • Bologna, Italy, 40138
        • Recruiting
        • Azienda Ospedaliero Universitaria di Bologna Policlinico S. Orsola - Malpighi- UO Medicina interna, malattie epatobiliari e immunoallergologiche
        • Contact:
      • Brescia, Italy, 25121
        • Recruiting
        • ASST degli Spedali Civili di Brescia- Medicina Generale 2
        • Contact:
      • Ferrara, Italy, 44124
        • Recruiting
        • Azienda Ospedaliero-Universitaria S. Anna di Ferrara- Clinica Medica
        • Contact:
      • Firenze, Italy, 50012
        • Recruiting
        • Ospedale Santa Maria Annunziata, Bagno a Ripoli, Firenze- Medicina 1
        • Contact:
      • Messina, Italy, 98124
        • Recruiting
        • AOU G. Martino- UOC Medicina Interna
        • Contact:
      • Milano, Italy, 20157
        • Recruiting
        • ASST Fatebenefratelli Sacco, Ospedale Luigi Sacco- Struttura Complessa di Medicina Interna
        • Contact:
      • Modena, Italy, 44124
        • Recruiting
        • AOU Modena - Policlinico di Modena - S.C. Medicina Interna
        • Contact:
          • Antonello Pietrangelo, MD PhD
          • Phone Number: 00390594222714
          • Email: pietra@unimore.it
      • Napoli, Italy, 80131
        • Recruiting
        • Azienda Ospedaliera Universitaria Federico II, Napoli- UOC Medicina Interna ad indirizzo metabolico e riabilitativo
        • Contact:
      • Novara, Italy, 28100
        • Recruiting
        • Ospedale Maggiore della Carità di Novara- SCDU Medicina Interna 1, AOU Maggiore della Carità
        • Contact:
      • Roma, Italy, 00128
        • Recruiting
        • Policlinico Universitario Campus Bio-Medico di Roma- UOC Medicina Interna
        • Contact:
      • Roma, Italy, 00189
        • Recruiting
        • Azienda Ospedaliero-Universitaria Sant'Andrea- UOC Medicina Interna
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

adult hospitalized internal medicine patient

Description

Inclusion Criteria:

  1. Patients of legal age (age >= 18 years).
  2. Informed consent according to Italian law.

Exclusion Criteria:

  • No specific exclusion criteria were identified.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
to evaluate the correlation between clinical complexity/multimorbidity of the hospitalized internal medicine patient, defined by the Cumulative Illness Rating Scale (CIRS), and mortality.
Time Frame: 12 months
to evaluate the correlation between clinical complexity/multimorbidity of the hospitalized internal medicine patient, defined by the Cumulative Illness Rating Scale (CIRS), and mortality. Cumulative Illness Rating Scale: severity index (minimum value is 1, maximum value is 5), comorbidity index (minimum value is 0, maximum value is 13). Higher scores mean worse outcome.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
to evaluate the correlation between pre-existing factors at hospitalization and clinical outcomes - to evaluate the association between disease severity parameters and clinical outcomes
Time Frame: 12 months
  • to evaluate the correlation between pre-existing factors at hospitalization, such as polypharmacy, age, prevalent chronic diseases (e.g. heart failure, respiratory failure and pneumonia, decompensated diabetes, etc.) and clinical outcomes such as mortality, length of hospital stay, intensity of care (transfer to units with higher clinical intensity), complications and rehospitalization
  • to evaluate the association between disease severity parameters (e.g. biohumoral, score, etc.) and clinical outcomes.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 24, 2024

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

June 1, 2028

Study Registration Dates

First Submitted

February 25, 2025

First Submitted That Met QC Criteria

March 10, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 10, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 207/2023/OSS/AOUMO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe